These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8995306)

  • 21. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
    Wakita T; Moradpour D; Tokushihge K; Wands JR
    J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.
    Tallet-Lopez B; Aldaz-Carroll L; Chabas S; Dausse E; Staedel C; Toulmé JJ
    Nucleic Acids Res; 2003 Jan; 31(2):734-42. PubMed ID: 12527783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligonucleotide-based strategies to inhibit human hepatitis C virus.
    Martinand-Mari C; Lebleu B; Robbins I
    Oligonucleotides; 2003; 13(6):539-48. PubMed ID: 15025918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamic studies on hairpin forming antisense-oligodeoxynucleotides directed against hepatitis C virus RNA.
    Lehmann TJ; Eisenhardt S; Engels JW
    Nucleosides Nucleotides; 1999; 18(6-7):1689-91. PubMed ID: 10474247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90.
    Watanabe N; Sawai H; Endo K; Shinozuka K; Ozaki H; Tanada S; Murata H; Sasaki Y
    Nucl Med Biol; 1999 Feb; 26(2):239-43. PubMed ID: 10100225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary structure and hybridization accessibility of hepatitis C virus 3'-terminal sequences.
    Smith RM; Walton CM; Wu CH; Wu GY
    J Virol; 2002 Oct; 76(19):9563-74. PubMed ID: 12208936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.
    Yamakawa H; Abe T; Saito T; Takai K; Yamamoto N; Takaku H
    Bioorg Med Chem; 1998 Jul; 6(7):1025-32. PubMed ID: 9730239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
    Nulf CJ; Corey D
    Nucleic Acids Res; 2004; 32(13):3792-8. PubMed ID: 15263060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.
    Laxton C; Brady K; Moschos S; Turnpenny P; Rawal J; Pryde DC; Sidders B; Corbau R; Pickford C; Murray EJ
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3105-14. PubMed ID: 21502629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
    Veal GJ; Agrawal S; Byrn RA
    Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of RNA function by oligonucleotides recognizing RNA structure.
    Toulmé JJ; Di Primo C; Moreau S
    Prog Nucleic Acid Res Mol Biol; 2001; 69():1-46. PubMed ID: 11550792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naked-eye colorimetric detection of HCV RNA mediated by a 5' UTR-targeted antisense oligonucleotide and plasmonic gold nanoparticles.
    Mohammed AS; Balapure A; Khaja MN; Ganesan R; Dutta JR
    Analyst; 2021 Mar; 146(5):1569-1578. PubMed ID: 33586713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of acceptor sites for antisense oligonucleotides on native folded RNA by fluorescence spectroscopy.
    Mahara A; Iwase R; Sakamoto T; Yamaoka T; Yamana K; Murakami A
    Bioorg Med Chem; 2003 Jul; 11(13):2783-90. PubMed ID: 12788352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation.
    Michel T; Martinand-Mari C; Debart F; Lebleu B; Robbins I; Vasseur JJ
    Nucleic Acids Res; 2003 Sep; 31(18):5282-90. PubMed ID: 12954764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.
    Gabler A; Krebs S; Seichter D; Förster M
    Nucleic Acids Res; 2003 Aug; 31(15):e79. PubMed ID: 12888531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.